PhaseBio Pharmaceuticals, Inc.
PHAS · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,665 | -$11,141 | $87,830 | -$31,924 |
| Dep. & Amort. | $603 | $601 | $606 | $130 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $715 | $597 | $150 | $720 |
| Change in WC | $9,562 | -$9,087 | $7,995 | $20,162 |
| Other Non-Cash | -$4,626 | -$3,854 | -$116,575 | $4,780 |
| Operating Cash Flow | -$10,411 | -$22,884 | -$19,994 | -$6,132 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$58 | -$49 | -$1,656 | -$638 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$58 | -$49 | -$1,656 | -$638 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $735 | $1,185 | $18 | -$15 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$415 | -$179 | $7,093 | -$1,329 |
| Financing Cash Flow | -$415 | -$179 | $7,093 | -$1,329 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,884 | -$23,112 | -$14,557 | -$8,099 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,688 | $41,800 | $56,357 | $64,456 |
| End Cash | $7,804 | $18,688 | $41,800 | $56,357 |
| Free Cash Flow | -$10,469 | -$22,933 | -$21,650 | -$6,770 |